Representatives of the company Novo Nordisk announced their intention to invest an additional $ 100 million. U.S. to build its R & D-center in Beijing.
The new building of the research center area of 12 thousand m2 will increase staff scientists from 130 to 200 and increase the scientific potential. This decision was made in the implementation of Novo Nordisk its core strategy, which is to provide opportunities for the entire spectrum of protein in China.
Mads Krogsgaard Thomson (Mads Krogsgaard Thomsen), executive vice president, said that China has a serious scientific study, and by investing in the creation of a new R & D-center, Novo Nordisk plans to use innovative approaches of Chinese scientists.
The current research center has made a significant contribution to the company's portfolio of research in the field of drugs for the treatment of diabetes and biopharmaceutical drugs used in other diseases.
Novo Nordisk was the first multinational corporation, opened a research center in China (1997). The current research center Novo Nordisk was founded in 2002 and over the years it has become one of the leaders in the field of molecular biology, protein chemistry and cell biology.
The new building of the research center area of 12 thousand m2 will increase staff scientists from 130 to 200 and increase the scientific potential. This decision was made in the implementation of Novo Nordisk its core strategy, which is to provide opportunities for the entire spectrum of protein in China.
Mads Krogsgaard Thomson (Mads Krogsgaard Thomsen), executive vice president, said that China has a serious scientific study, and by investing in the creation of a new R & D-center, Novo Nordisk plans to use innovative approaches of Chinese scientists.
The current research center has made a significant contribution to the company's portfolio of research in the field of drugs for the treatment of diabetes and biopharmaceutical drugs used in other diseases.
Novo Nordisk was the first multinational corporation, opened a research center in China (1997). The current research center Novo Nordisk was founded in 2002 and over the years it has become one of the leaders in the field of molecular biology, protein chemistry and cell biology.
No comments:
Post a Comment